Craft

Enzymatica

Stock Price

KR1.8

2024-10-29

Market Capitalization

KR429.6 M

2024-10-29

Revenue

KR53.9 M

FY, 2025

Enzymatica Summary

Company Summary

Overview
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. Its products are based on a barrier technology that includes marine enzymes. The company has three models for sales of its products: mouth spray as a medical device, mouth spray as a cosmetic product and an enzyme formulation that is included in its customers' skincare products.
Type
Public
Status
Active
Founded
2007
HQ
Lund, SE | view all locations
Website
http://www.enzymatica.se
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Claus Egstrand

    Claus Egstrand, Chief Operating Officer

    • Ulf Blom

      Ulf Blom, Co-Founder of Enzymatica AB & Director of Innovation & Pipeline

    • Therese Filmersson

      Therese Filmersson, CFO & Deputy CEO

    • Johan Lindvall

      Johan Lindvall, Director Global Project Management

    Operating MetricsView all

    Study Centres (ColdZyme, United Kingdom)

    1

    Sep, 2016

    Enrollment Participants (ColdZyme, United Kingdom)

    88

    Sep, 2016

    Study Centres (ColdZyme, Germany)

    10

    Aug, 2019

    LocationsView all

    2 locations detected

    • Lund, Skåne län HQ

      Sweden

      Scheelevägen 17

    • Reykjavík

      Iceland

      Fiskislóð 39

    Enzymatica Financials

    Summary Financials

    Revenue (Q1, 2026)
    kr11.4M
    Gross profit (Q1, 2026)
    kr6.5M
    Net income (Q1, 2026)
    (kr13.5M)
    Cash (Q1, 2026)
    kr26.1M
    EBIT (Q1, 2026)
    (kr13.6M)
    Enterprise value
    $404.2M

    Footer menu